Use the Back button in your browser to see the other results of your search or to select another record.
A randomised, pragmatic clinical trial of acupuncture plus standard care versus standard care alone for chemotherapy induced peripheral neuropathy (ACUFOCIN) [with consumer summary] |
Stringer J, Ryder WD, Mackereth PA, Misra V, Wardley AM |
European Journal of Oncology Nursing 2022 Oct;60:102171 |
clinical trial |
7/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|